First pill for male impotence approved in US
BMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7138.1111c (Published 11 April 1998) Cite this as: BMJ 1998;316:1111- Fred Charatan
- Florida
An oral drug for treating erectile dysfunction has been approved by the Food and Drug Administration in the United States. Sildenafil citrate (Viagra) is the first in a new class of drugs known as phosphodiesterase type 5 inhibitors that work by improving blood flow to the penis.
There is a potentially large market for the drug. An estimated 30 million men in the United States are affected by erectile dysfunction, with the prevalence increasing with age. Less than 10% of these men, however, seek treatment. Dr Gregory Broderick, director of the Center for the Study of Male Sexual Dysfunction at the University of Pennsylvania, said: “In the past a man suffering from erectile dysfunction needed terrific personal motivation to see a doctor, mainly because the treatments available were so unpleasant.” He felt that …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.